Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO Reexam ...
The problem with the reexam percentages is that we do not know what percentage of the 60% that get modified in some way are modications that would have significant impact on infringement and the dollar amounts paid. If we assume that only 10% of the modifications have significant impace, (same percentage as patent invalidity) then 84% of all reexams would fall into the category of either no change or without significant change. Anyone have a feel for how significant most of these modifications are? That info would indeed be nice to know. Opty
Share
New Message
Please login to post a reply